Financings in Brief: ThermoTrex
This article was originally published in The Gray Sheet
ThermoTrex: Firm's Trex Medical subsidiary begins rights offering under which shareholders of ThermoTrex receive 0.10 rights per share of ThermoTrex to purchase one share of Trex Medical at its initial offering price. Trex Medical filed a registration statement in April for its IPO ("The Gray Sheet" April 8, p. 18). The rights are exercisable through June 24, 1996. Closing of the rights offering is contingent upon closing of the initial Trex Medical public offering...
You may also be interested in...
Listerine mouthwash drove J&J’s oral care sales up 11.4% in the fourth quarter. Tylenol for adults was the star of its OTC drug business but weakness of children’s Tylenol products and other OTCs led to flat sales.
Nutritional Brands rolls out NB Pure as brand, including logo, packaging design and website, for all its supplements after 25 years. “When you looked at our label for one brand and looked at the label for another brand, there was no symmetry between the two,” says CEO Danna Pratt.
Sanofi will fill and package 100 million doses of a rival vaccine for the European market in 2021 in a sign of how the industry is working to meet an unprecedented demand for COVID-19 vaccines.